Authors: Kaiser, B Paintz, M Scholz, O Kunitada, S Fareed, J

Citation: B. Kaiser et al., A synthetic inhibitor of factor Xa, DX-9065a, reduces proliferation of vascular smooth muscle cells in vivo in rats, THROMB RES, 98(2), 2000, pp. 175-185

Authors: Tanabe, K Morishima, Y Shibutani, M Terada, Y Hara, T Shinohara, Y Aoyagi, K Kunitada, S Kondo, T

Citation: K. Tanabe et al., DX-9065a, an orally active factor Xa inhibitor, does not facilitate haemorrhage induced by tail transection or gastric ulcer at the effective doses in rat thrombosis model, THROMB HAEM, 81(5), 1999, pp. 828-834

Authors: Kunitada, S Nagahara, T Hara, T

Citation: S. Kunitada et al., Inhibitors of factor Xa, HANDB EXP P, 132, 1999, pp. 397-420

Authors: Tanabe, K Terada, Y Shibutani, T Kunitada, S Kondo, T

Citation: K. Tanabe et al., A specific inhibitor of factor Xa, DX-9065a, exerts effective protection against experimental tumor-induced disseminated intravascular coagulation inrats, THROMB RES, 96(2), 1999, pp. 135-143

Authors: Murayama, N Tanaka, M Kunitada, S Yamada, H Inoue, T Terada, Y Fujita, M Ikeda, Y

Citation: N. Murayama et al., Tolerability, pharmacokinetics, and pharmacodynamics of DX-9065a, a new synthetic potent anticoagulant and specific factor Xa inhibitor, in healthy male volunteers, CLIN PHARM, 66(3), 1999, pp. 258-264